Home / Biotechnology / Endocrine Testing Market By Test Type (E2 Testing, FSH Testing, hCG Hormone Testing, LH Testing, DHEAS Testing, Progesterone Testing, Testosterone Testing, TSH Testing, Prolactin Testing, Cortisol Testing, Insulin Testing, Others), By Endocrine Disorder, By Testing Technology , By End-user - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Endocrine Testing Market By Test Type (E2 Testing, FSH Testing, hCG Hormone Testing, LH Testing, DHEAS Testing, Progesterone Testing, Testosterone Testing, TSH Testing, Prolactin Testing, Cortisol Testing, Insulin Testing, Others), By Endocrine Disorder, By Testing Technology , By End-user - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Published: Oct 2017 | Report Code: 58725-10-17

The endocrine system is a group of glands that create and release hormones to control important bodily functions, such as metabolism, growth, reproduction etc. The endocrine system plays a vital role in prevention of several chronic and metabolic diseases. Generally, endocrine disorders are divided into two categories: diseases resulting when the glands over-produce or under-produce (hormone imbalance) and diseases sue to development of lesions in the endocrine system.

The purpose of this research study titled ‘Endocrine Testing Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global endocrine testing market. This report presents and analyzes the major trends prevalent in the global endocrine testing market and the market size and forecast.

This report categorizes the global endocrine testing market in terms of test type, endocrine disorder, testing technology, end-users and geographical distribution. For the purpose of this study, the test types considered include estradiol (E2) testing, follicle stimulating hormone (FSH) testing, human chorionic gonadotropin (hCG) hormone testing, luteinizing hormone (LH) testing, dehydroepiandrosterone sulfate (DHEAS) testing, progesterone testing, testosterone testing, thyroid stimulating hormone (TSH) testing, prolactin testing, cortisol testing, insulin testing and others. The endocrine disorders studied in this report are categorized as adrenal disorders, calcium problems, glucose (islet cells) disorders, male and female gonadal problems, heart disorders, hypertensive disorders, thyroid disorders and pituitary disorders.

Based on testing technologies, the global endocrine testing market is studied for immunoassay technology, tandem mass spectrometry, sensors technology, monoclonal and polyclonal antibody technology, clinical chemistry technology and others. This report also categorizes the global endocrine testing market by end-users such as hospitals, clinical laboratories, research and academia, and others. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global endocrine testing market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional analysis is presented in terms of test type, endocrine disorder, testing technology, end-users and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global endocrine testing market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the endocrine testing market. The key players profiled in this report are Abbott Laboratories, AB Sciex Pte Ltd., Agilent Technologies, Inc., Biomedical Technologies (Alfa Aesar), bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Ortho-clinical Diagnostics, Quest Technology Pte Ltd., Sysmex Corporation and Teleflex Incorporated.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Endocrine Testing Market Portraiture
2.1.1. Global Endocrine Testing Market, by Test Type, 2016
2.1.2. Global Endocrine Testing Market, by Endocrine Disorders, 2016
2.1.3. Global Endocrine Testing Market, by Testing Technology, 2016
2.1.4. Global Endocrine Testing Market, by End-user, 2016
2.1.5. Global Endocrine Testing Market, by Geography, 2016

Chapter 3. Endocrine Testing: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition, by Test Type
4.2. Estradiol (E2) Testing
4.3. Follicle Stimulating Hormone (FSH) Testing
4.4. Human Chorionic Gonadotropin (hCG) Hormone Testing
4.5. Luteinizing Hormone (LH) Testing
4.6. Dehydroepiandrosterone Sulfate (DHEAS) Testing
4.7. Progesterone Testing
4.8. Testosterone Testing
4.9. Thyroid Stimulating Hormone (TSH) Testing
4.10. Prolactin Testing
4.11. Cortisol Testing
4.12. Insulin Testing
4.13. Others

Chapter 5. Global Endocrine Testing Market, by Endocrine Disorders, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition, by Endocrine Disorders
5.2. Adrenal Disorders
5.3. Calcium Problems
5.4. Glucose (islet cells) Disorders
5.5. Male and Female Gonadal Problems
5.6. Heart Disorders
5.7. Hypertensive Disorders
5.8. Thyroid Disorders
5.9. Pituitary Disorders

Chapter 6. Global Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition, by Testing Technology
6.2. Immunoassay Technology
6.3. Tandem Mass Spectrometry
6.4. Sensors Technology
6.5. Monoclonal and Polyclonal Antibody Technology
6.6. Clinical Chemistry Technology
6.7. Others

Chapter 7. Global Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
7.1. Overview
7.1.1. Attractive Investment Proposition, by Testing Technology
7.2. Hospitals
7.3. Clinical Laboratories
7.4. Research and Academia
7.5. Others

Chapter 8. Global Endocrine Testing Market, by Geography, 2015 – 2025
8.1. Overview
8.2. North America Endocrine Testing Market Analysis, 2015 – 2025
8.2.1. North America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.2.2. North America Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
8.2.3. North America Endocrine Testing Market, by Endocrine Disorders, 2015 – 2025 (US$ Mn)
8.2.4. North America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.2.5. North America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.2.5.1. U.S.
8.2.5.2. Canada
8.3. Europe Endocrine Testing Market Analysis, 2015 – 2025
8.3.1. Europe Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.3.2. Europe Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
8.3.3. Europe Endocrine Testing Market, by Endocrine Disorders, 2015 – 2025 (US$ Mn)
8.3.4. Europe Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.3.5. Europe Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.3.5.1. U.K.
8.3.5.2. Germany
8.3.5.3. France
8.3.5.4. Italy
8.3.5.5. Spain
8.3.5.6. Rest of Europe
8.4. Asia Pacific Endocrine Testing Market Analysis, 2015 – 2025
8.4.1. Asia Pacific Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.4.2. Asia Pacific Endocrine Testing Market, by Endocrine Disorders, 2015 – 2025 (US$ Mn)
8.4.3. Asia Pacific Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
8.4.4. Asia Pacific Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.4.5. Asia Pacific Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.4.5.1. China
8.4.5.2. Japan
8.4.5.3. Rest of Asia Pacific
8.5. Latin America Endocrine Testing Market Analysis, 2015 – 2025
8.5.1. Latin America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.5.2. Latin America Endocrine Testing Market, by Endocrine Disorders, 2015 – 2025 (US$ Mn)
8.5.3. Latin America Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
8.5.4. Latin America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.5.5. Latin America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.5.5.1. Brazil
8.5.5.2. Mexico
8.5.5.3. Rest of Latin America
8.6. Middle East & Africa Endocrine Testing Market Analysis, 2015 – 2025
8.6.1. MEA Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.6.2. MEA Endocrine Testing Market, by Endocrine Disorders, 2015 – 2025 (US$ Mn)
8.6.3. MEA Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
8.6.4. MEA Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.6.5. MEA Endocrine Testing Market, by Region, 2015 – 2025 (US$ Mn)
8.6.5.1. GCC
8.6.5.2. Rest of Middle East and Africa

Chapter 9. Company Profiles
9.1. Abbott Laboratories, Inc.
9.1.1. Business Description
9.1.2. Financial Information (Subject to data availability)
9.1.3. Testing Technology Portfolio
9.1.4. Key Developments
9.2. AB Sciex Pte Ltd.
9.3. Agilent Technologies, Inc.
9.4. Biomedical Technologies (Alfa Aesar)
9.5. bioMérieux SA
9.6. Bio-Rad Laboratories, Inc.
9.7. DiaSorin
9.8. F. Hoffmann-La Roche Ltd.
9.9. Laboratory Corporation of America Holdings
9.10. Ortho-clinical Diagnostics
9.11. Quest Technology Pte Ltd.
9.12. Sysmex Corporation
9.13. Teleflex Incorporated

List of Tables

TABLE 1 Global Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Endocrine Testing Market, by Endocrine Disorder, 2015 – 2025 (US$ Mn)
TABLE 3 Global Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
TABLE 4 Global Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 5 North America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Endocrine Testing Market, by Endocrine Disorder, 2015 – 2025 (US$ Mn)
TABLE 7 North America Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
TABLE 8 North America Endocrine Testing Market, by End User, 2015 – 2025 (US$ Mn)
TABLE 9 North America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Endocrine Testing Market, by Endocrine Disorder, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
TABLE 13 Europe Endocrine Testing Market, by End User, 2015 – 2025 (US$ Mn)
TABLE 14 Europe Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Endocrine Testing Market, by Endocrine Disorder, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
TABLE 18 Asia Pacific Endocrine Testing Market, by End User, 2015 – 2025 (US$ Mn)
TABLE 19 Asia Pacific Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Endocrine Testing Market, by Endocrine Disorder, 2015 – 2025 (US$ Mn)
TABLE 22 Latin America Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
TABLE 23 Latin America Endocrine Testing Market, by End User, 2015 – 2025 (US$ Mn)
TABLE 24 Latin America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East and Africa Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 26 Middle East and Africa Endocrine Testing Market, by Endocrine Disorder, 2015 – 2025 (US$ Mn)
TABLE 27 Middle East and Africa Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
TABLE 28 Middle East and Africa Endocrine Testing Market, by End User, 2015 – 2025 (US$ Mn)
TABLE 29 Middle East and Africa Endocrine Testing Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 30 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 31 AB Sciex Pte Ltd.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 32 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 33 Biomedical Technologies (Alfa Aesar): Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 34 bioMérieux SA: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 35 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 36 DiaSorin: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 37 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 38 Laboratory Corporation of America Holdings: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 39 Ortho-clinical Diagnostics: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 40 Quest Technology Pte Ltd.: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 41 Sysmex Corporation: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)
TABLE 42 Teleflex Incorporated: Company Snapshot (Business Description; Financial Information; Test Type Portfolio; News Coverage)

List of Figures

FIG. 1 Endocrine Testing: Market Segmentation
FIG. 2 Global Endocrine Testing Market, by Test Type, 2016 (US$ Mn)
FIG. 3 Global Endocrine Testing Market, by Testing Technology, 2016 (US$ Mn)
FIG. 4 Global Endocrine Testing Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Attractive Investment Proposition, by Test Type
FIG. 8 Global Estradiol (E2) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Follicle Stimulating Hormone (FSH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Human Chorionic Gonadotropin (hCG) Hormone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Luteinizing Hormone (LH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Dehydroepiandrosterone Sulfate (DHEAS) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Progesterone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Testosterone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Thyroid Stimulating Hormone (TSH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Prolactin Testing Market, 2015 – 2025 (US$ Mn)
FIG. 17 Global Cortisol Testing Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Insulin Testing Market, 2015 – 2025 (US$ Mn)
FIG. 19 Global Other Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 20 Attractive Investment Proposition, by Endocrine Disorders
FIG. 21 Global Endocrine Testing Market for Adrenal Disorders, 2015 – 2025 (US$ Mn)
FIG. 22 Global Endocrine Testing Market for Calcium Problems, 2015 – 2025 (US$ Mn)
FIG. 23 Global Endocrine Testing Market for Glucose (islet cells) Disorders, 2015 – 2025 (US$ Mn)
FIG. 24 Global Endocrine Testing Market for Male and Female Gonadal Problems, 2015 – 2025 (US$ Mn)
FIG. 25 Global Endocrine Testing Market for Heart Disorders, 2015 – 2025 (US$ Mn)
FIG. 26 Global Endocrine Testing Market for Hypertensive Disorders, 2015 – 2025 (US$ Mn)
FIG. 27 Global Endocrine Testing Market for Thyroid Disorders, 2015 – 2025 (US$ Mn)
FIG. 28 Global Endocrine Testing Market for Pituitary Disorders, 2015 – 2025 (US$ Mn)
FIG. 29 Attractive Investment Proposition, by Testing Technology
FIG. 30 Global Endocrine Testing Market for Immunoassay Technology, 2015 – 2025 (US$ Mn)
FIG. 31 Global Endocrine Testing Market for Tandem Mass Spectrometry, 2015 – 2025 (US$ Mn)
FIG. 32 Global Endocrine Testing Market for Sensors Technology, 2015 – 2025 (US$ Mn)
FIG. 33 Global Endocrine Testing Market for Monoclonal and Polyclonal Antibody Technology, 2015 – 2025 (US$ Mn)
FIG. 34 Global Endocrine Testing Market for Clinical Chemistry Technology, 2015 – 2025 (US$ Mn)
FIG. 35 Global Endocrine Testing Market for Other Technologies, 2015 – 2025 (US$ Mn)
FIG. 36 Attractive Investment Proposition, by End-user
FIG. 37 Global Endocrine Testing Market in Hospitals, 2015 – 2025 (US$ Mn)
FIG. 38 Global Endocrine Testing Market in Clinical Laboratories, 2015 – 2025 (US$ Mn)
FIG. 39 Global Endocrine Testing Market in Research and Academia, 2015 – 2025 (US$ Mn)
FIG. 40 Global Endocrine Testing Market in Other End-uses, 2015 – 2025 (US$ Mn)
FIG. 41 U.S. Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 42 Canada Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 43 U.K. Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 44 Germany Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 45 France Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 46 Italy Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 47 Spain Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 48 Rest of Europe Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 49 China Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 50 Japan Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 51 Rest of Asia Pacific Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 52 Brazil Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 53 Mexico Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 54 Rest of Latin America Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 55 GCC Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 56 Rest of Middle East and Africa Endocrine Testing Market, 2015 – 2025 (US$ Mn)

Based on the type of disorders, the global endocrine testing market is segmented as follows:

  • Adrenal Disorders
  • Calcium Problems
  • Glucose (islet cells) Disorders
  • Male and Female Gonadal Problems
  • Heart Disorders
  • Hypertensive Disorders
  • Thyroid Disorders
  • Pituitary Disorders

Endocrine Testing Market

Diabetes is among the most prominent areas where endocrine testing is widely used. As the global prevalence of diabetes is on perpetual rise, it is also opined that there is still a huge population of undiagnosed patients. People can have prediabetes or type 2 diabetes for several years without exhibiting distinguishable symptoms. As a matter of fact, type 2 diabetes often goes undiagnosed until the related complications appear. Such complications include renal disease, vision impairment and even nerve damage. If not diagnosed in time, and left untreated, diabetes can result in several complications and eventual mortality. Efficient and accurate diagnosis of diabetes is very critical to make the needed lifestyle changes or take medications for disease management. It is often recommended to perform diabetes screening in people with high risk of developing diabetes.

For the purpose of this study, global endocrine testing market is studied for the following test types:

  • Estradiol (E2) Testing
  • Follicle Stimulating Hormone (FSH) Testing
  • Human Chorionic Gonadotropin (hCG) Hormone Testing
  • Luteinizing Hormone (LH) Testing
  • Dehydroepiandrosterone Sulfate (DHEAS) Testing
  • Progesterone Testing
  • Testosterone Testing
  • Thyroid Stimulating Hormone (TSH) Testing
  • Prolactin Testing
  • Cortisol Testing
  • Insulin Testing
  • Others

Endocrine Testing Market

Among the considered test types, thyroid stimulating hormone testing and insulin testing together will capture the largest market share throughout the forecast period 2017-2025. Thyroid function disorders are common worldwide and screening and diagnosis forms a critical part of disease management. Symptoms of thyroid disorders are extremely prevalent in general population and are non-specific. Increasing information available too general public has let to voluntary testing by patients worldwide. TSH, T4 and anti-TPO antibodies are the three most important biochemical tests for assessing thyroid function. Of these, the TSH testing assay is the most reliable test for diagnosis of primary hypo- and hyperthyroidism, where the first generation TSH testing can only diagnose hypothyroidism.

For the purpose of this study, the global endocrine testing market is segmented as per the following technologies:

  • Immunoassay Technology
  • Tandem Mass Spectrometry
  • Sensors Technology
  • Monoclonal and Polyclonal Antibody Technology
  • Clinical Chemistry Technology
  • Others

 

Endocrine Testing Market

Growing prevalence of metabolic disorders, sexual dysfunction, diabetes, renal diseases and obesity has led to emergence of heightened demand for endocrine testing methods. Regular monitoring of endocrine hormones play a critical role in the management of diabetes and related complications across all demographics. There is also an increasing significance of obesity as co-morbidity in the growing prevalence of disorders of the reproductive system, strokes, cardiovascular diseases and cancer. This increase in the patient pool is expected to favor the growth of endocrine testing market. However, high costs of novel testing technologies may restrain widespread acceptance of novel tests, especially in developing countries. Among the currently available testing technologies, immunoassay technology is the largest revenue generating segment and it is anticipated that the trend shall continue during the forecast period. Technologies such as tandem mass spectrometry will witness significant traction through the forecast period as a result of their proven precision and accuracy in result delivery.

Geographically, the global endocrine testing market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Endocrine Testing Market
 

North America (U.S. and Canada) is the clear leader in the global endocrine testing market, followed by Europe. Significant prevalence of obesity, chronic endocrine disorders such as diabetes and thyroid diseases, and reproductive health disorders are the key factors contributing to the dominance of North America market. Furthermore, supportive government regulations facilitating swift adoption of novel testing technologies and evolved reimbursement scenario additionally drive the North America endocrine testing market. On the other hand, huge population base and rising incidence of lifestyle-related diseases has led to the emergence of Asia Pacific as the fastest progressing regional market for endocrine testing.

The detailed regional classification of the global endocrine testing market is as follows:

  • North America (U.S. & Canada)
  • Europe (U.K., Germany, France, Italy, Spain and Rest of Europe)
  • Asia Pacific (China, Japan, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients